Yizhou Yu addresses the lack of personalised treatments for Alzheimer’s disease by investigating genetic, cellular, and population-level aspects. He combined laboratory techniques and machine learning to identify a novel pathway, leading to the development of probiotic bacteria that delay neuron death in animal models, offering a potential solution for Alzheimer’s disease.

Further Activities to have a look at